Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Revenue of $4.1 Million, up 38% U.S. Product Revenue up $1.2 Million or 142% High U.S. Growth of New Dermatology Products EBITDAS for First Quarter of Fiscal 2013 is Negative $22,000...
-
Oculus Innovative Sciences Announces Fiscal First Quarter 2013 Financial Results and Conference Call
PETALUMA, Calif., July 25, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced that the financial results for its fiscal first quarter 2013, ended June 30, 2012,...
-
PETALUMA, Calif., July 10, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced that the Chinese State Food and Drug Administration (SFDA) has approved...
-
Agreement Includes Upfront and Clinically Based Milestone Payments; Double-Digit Escalating Royalties on Future Sales Oculus to Host Conference Call at 11:00 a.m. EDT, June 26,...
-
SACRAMENTO, Calif., June 14, 2012 (GLOBE NEWSWIRE) -- Napa Valley Nutritionals (www.nvnutritionals.com) today introduced two Glucorein™ chlorogenic-acid coffee drinks—Brazilian Decaf and...
-
PETALUMA, Calif., June 7, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced financial results for the fourth quarter of fiscal year 2012, ended March 31, 2012....
-
PETALUMA, Calif., May 24, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced that the financial results for its fiscal fourth quarter 2012, ended March 31, 2012,...
-
PETALUMA, Calif., May 11, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a commercial healthcare company that designs, produces and markets innovative, safe and effective...
-
PETALUMA, Calif., May 9, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a commercial healthcare company that designs, produces and markets innovative, safe and effective...
-
PETALUMA, Calif., April 26, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a commercial healthcare company that designs, produces and markets innovative, safe and effective...